UMIN-CTR Clinical Trial

Unique ID issued by UMIN UMIN000003628
Receipt number R000004399
Scientific Title Toyama Anti-arteriosclerosis and Plaque Assessment Trial by Aggressive Lipid Lowering Therapy with Pitavastatin in Peripheral Artery Disease
Date of disclosure of the study information 2010/06/01
Last modified on 2010/05/17 18:20:22

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information

Public title

Toyama Anti-arteriosclerosis and Plaque Assessment Trial by Aggressive Lipid Lowering Therapy with Pitavastatin in Peripheral Artery Disease

Acronym

TULIP

Scientific Title

Toyama Anti-arteriosclerosis and Plaque Assessment Trial by Aggressive Lipid Lowering Therapy with Pitavastatin in Peripheral Artery Disease

Scientific Title:Acronym

TULIP

Region

Japan


Condition

Condition

Patients with peripheral artery disease and hypercholesterolemia

Classification by specialty

Cardiology Endocrinology and Metabolism

Classification by malignancy

Others

Genomic information

NO


Objectives

Narrative objectives1

To compare the efficacy of intensive with conventional lipid lowering therapy, on patients with peripheral artery disease and hypercholesterolemia.

Basic objectives2

Efficacy

Basic objectives -Others


Trial characteristics_1


Trial characteristics_2


Developmental phase



Assessment

Primary outcomes

claudication time on Treadmill exercise test

Key secondary outcomes



Base

Study type

Interventional


Study design

Basic design

Parallel

Randomization

Randomized

Randomization unit


Blinding

Open -no one is blinded

Control

Active

Stratification


Dynamic allocation


Institution consideration


Blocking


Concealment



Intervention

No. of arms

2

Purpose of intervention

Treatment

Type of intervention

Medicine

Interventions/Control_1

intensive lipid lowering therapy with Pitavastatin, 1 to 4mg once daily, to achieve serum LDL cholesterol level less than 80mg/dl.

Interventions/Control_2

conventional lipid lowering therapy with Pitavastatin, 1 to 4mg once daily, to achieve serum LDL cholesterol level less than 120mg/dl in patients without coronary heart disease or less than 100mg/dl in patients with coronary heart disease.

Interventions/Control_3


Interventions/Control_4


Interventions/Control_5


Interventions/Control_6


Interventions/Control_7


Interventions/Control_8


Interventions/Control_9


Interventions/Control_10



Eligibility

Age-lower limit

40 years-old <=

Age-upper limit

85 years-old >

Gender

Male and Female

Key inclusion criteria

1) Patient without coronary artery disease, whose LDL cholesterol >= 120mg/dl
2) Patient with coronary artery disease, whose LDL cholesterol >= 100mg/dl
3) Ankle Brachial Pressure Index (ABI) <= 0.9

Key exclusion criteria

1) Following "contraindication" or "essentially contraindication" of pitavastatin as follows:
severe liver injury or biliary obstruction
patients taking cyclosporin
pregnant or possible pregnant women or
breast-feeding women
patients with renal dysfunction and taking fibrates
2) patients already taking pitavastatin
3) patients with maintenance dialysis
4) patients who plan to undergo or underwent bilateral lower limb revascularization within within 3 months.
5) patients with severe peripheral artery disease (Fontaine classification class 4)
6) patient with previous cerebral hemorrhage
7) patients who judged inadequate by the co-execution doctor

Target sample size

50


Research contact person

Name of lead principal investigator

1st name
Middle name
Last name Hiroshi Inoue

Organization

University of Toyama

Division name

Graduate school of medicine and pharmaceutical science, The Second Department of Internal Medicine

Zip code


Address

2630 Sugitani, Toyama

TEL

076-434-7297

Email



Public contact

Name of contact person

1st name
Middle name
Last name Tomoki Kameyama

Organization

University of Toyama

Division name

Graduate school of medicine and pharmaceutical science, The Second Department of Internal Medicine

Zip code


Address

2630 Sugitani, Toyama

TEL

076-434-7297

Homepage URL


Email



Sponsor or person

Institute

The Second Department of Internal Medicine, University of Toyama, Graduate school of medicine and pharmaceutical science,

Institute

Department

Personal name



Funding Source

Organization

The Second Department of Internal Medicine, University of Toyama, Graduate school of medicine and pharmaceutical science,

Organization

Division

Category of Funding Organization

Self funding

Nationality of Funding Organization



Other related organizations

Co-sponsor


Name of secondary funder(s)



IRB Contact (For public release)

Organization


Address


Tel


Email



Secondary IDs

Secondary IDs

NO

Study ID_1


Org. issuing International ID_1


Study ID_2


Org. issuing International ID_2


IND to MHLW



Institutions

Institutions



Other administrative information

Date of disclosure of the study information

2010 Year 06 Month 01 Day


Related information

URL releasing protocol


Publication of results

Unpublished


Result

URL related to results and publications


Number of participants that the trial has enrolled


Results


Results date posted


Results Delayed


Results Delay Reason


Date of the first journal publication of results


Baseline Characteristics


Participant flow


Adverse events


Outcome measures


Plan to share IPD


IPD sharing Plan description



Progress

Recruitment status

Preinitiation

Date of protocol fixation

2010 Year 05 Month 24 Day

Date of IRB


Anticipated trial start date

2010 Year 06 Month 01 Day

Last follow-up date


Date of closure to data entry


Date trial data considered complete


Date analysis concluded



Other

Other related information



Management information

Registered date

2010 Year 05 Month 17 Day

Last modified on

2010 Year 05 Month 17 Day



Link to view the page

Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000004399


Research Plan
Registered date File name

Research case data specifications
Registered date File name

Research case data
Registered date File name